Introduction
The functional repertoire of both infiltrating and in situ inflammatory cells includes the biosynthesis and release of leukotrienes (LTs) derived from the 5-1ipoxygenation of arachidonic acid (AA). Functionally, these compounds can be divided into two classes: (1) the dihydroxy acid LTB4, which is a powerful chemotactic, aggregative and chemokinetic agent; and (2) the cysteinyl-containing LTs C4, D and E; collectively termed the 'slow-reacting substance of anaphylaxis' or SRS-A. 2 Whereas LTB has relatively few myotropic activities, 3 the C6 amino acid-substituted cysteinyl LTs are potent contractors of both vascular and non-vascular smooth muscle. The relative potencies of these compounds and their prominence in biological fluids and inflammatory exudates suggest a role in the pathophysiology of human bronchial asthma and other immediate hypersensitivity reactions. 4 Under the appropriate conditions, it has now been shown that Ca 2+ mobilization can synergize with protein kinase C (PKC) activation to enhance the formation of LTs in human eosinophils, 5 human neutrophils [6] [7] [8] 
